FindTrial
Sign In

Effect of the Homoeopathic Medicine Simarouba glauca in the treatment of Rheumatoid Arthritis

Single Blind Randomized Experimental Study to Assess the Efficacy of Simarouba glauca 6C, 12C and 30C in the Treatment of Rheumatoid Arthritis Patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/10/028751
Enrollment
30
Registered
2020-10-29
Start date
Unknown
Completion date
Unknown
Last updated
2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M06- Other rheumatoid arthritis Health Condition 2: M05- Rheumatoid arthritis with rheumatoid factor

Interventions

Intervention1: Simarouba glauca 6C: 5 Medicated Globules of 30 Size will be prescribed orally in morning & night every day before food to each patient for Minimum 90 days duration. Intervention2: Sima

Sponsors

Vinayaka Missions Homoeopathic Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Clinically Diagnosed Patients fulfilling the 2010 American College of Rheumatology / European League Against Rheumatism Classification Criteria for Rheumatoid Arthritis.

Exclusion criteria

Exclusion criteria: Patients with Systemic Complications and Deformities. Patients with Extra-articular manifestations. Patients under Chronic medication for Rheumatoid Arthritis.

Design outcomes

Primary

MeasureTime frame
Reduction in Serum Rheumatoid Factor and Erythrocyte Sedimentation Rate levels of each Patient after the completion of treatmentTimepoint: 90 Days—

Secondary

MeasureTime frame
Reduction in the â??Rheumatoid Arthritis Impact of Disease (RAID) Questionnaire Scoreâ??Timepoint: 90 Days—

Countries

India

Contacts

Public ContactDr H Venkatesan

Vinayaka Missions Homoeopathic Medical College and Hospital

venkathompath@gmail.com9865134561

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026